Press Releases

SAN JOSE, Calif.--(BUSINESS WIRE)-- Heuron, a specialized medical AI startup focused on brain and neurological disorders based in South Korea, announced that its non-contrast CT imaging analysis solution, Heuron ICH, has received FDA 510(k) clearance. This marks the first FDA approval of an AI-based brain disorder analysis solution from Korea for computer-aided triage and notification devices (CADt).

This press release features multimedia. View the full release... (continue reading...)

NORWALK, Conn., May 23, 2024 /PRNewswire/ -- Terex Corporation (NYSE: TEX) announced that its Board of Directors declared a quarterly dividend of $0.17 per share. The dividend is to be paid on June 20, 2024 to all stockholders of record as of the close of business on June 6, 2024.

About TerexTerex is a global manufacturer of materials processing... (continue reading...)

NEW YORK, May 23, 2024 /PRNewswire/ -- IAC (NASDAQ: IAC) will participate in the 52nd Annual TD Cowen Technology, Media and Telecom Conference on Thursday, May 30, 2024. Christopher Halpin, Executive Vice President, CFO and COO of IAC will participate in a fireside chat at 11:25 a.m. ET. Both a live audio webcast and replay of the fireside chat will be available to the public in the IR section of IAC's website at https://ir.iac.com/events-and-presentations.... (continue reading...)

MIAMI--(BUSINESS WIRE)-- LuxUrban Hotels Inc. (“LuxUrban” or the “Company”) (Nasdaq: LUXH), a hospitality company which leases entire existing hotels on a long-term basis and rents rooms in its hotels to business and vacation travelers, today announced that it closed its previously announced public offering of 35,075,000 shares of common stock, including the full exercise by the underwriters of their over-allotment option to purchase 4,575,000 shares of... (continue reading...)

NEW YORK, May 23, 2024 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Altimmune, Inc. (“Altimmune” or the “Company”) (NASDAQ: ALT) for violations of the federal securities laws on behalf of investors who purchased or acquired Altimmune common stock between December 1, 2023 and April 26, 2024, inclusive (the “Class Period”).

On May 6,... (continue reading...)